Sabrina H Kaplan, MD

Medical Toxicology Fellow V
Rocky Mountain Poison & Drug Safety
Denver, Colorado

Disclosure information not submitted.

Presentation(s):

• Association between per capita prescribing and abuse of tapentadol and other opioids among individuals entering treatment for opioid use disorders

  POSTER ABSTRACT

• Changes in oxycodone misuse and abuse trends across COVID-19: A look back

  POSTER ABSTRACT

• Differences in the severity of medical outcomes of exposures reported to poison centers involving XTAMPZA® ER and other opioid analgesics

  POSTER ABSTRACT

• Real-world impact of abuse-deterrent formulation of XTAMPZA ER in the context of behaviors around tampering with XTAMPZA® ER and other opioid products

  POSTER ABSTRACT

• Use of Causal Framework to Evaluate Effect of Abuse Deterrent Properties of XTAMPZA ER on Opioid Tampering in a Post-Market Setting

  POSTER ABSTRACT